These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 7563873

  • 21. Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California.
    Yu MC, Yuan JM, Ross RK, Govindarajan S.
    Hepatology; 1997 Jan; 25(1):226-8. PubMed ID: 8985295
    [Abstract] [Full Text] [Related]

  • 22. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M.
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [Abstract] [Full Text] [Related]

  • 23. The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma.
    Chiba T, Matsuzaki Y, Abei M, Shoda J, Tanaka N, Osuga T, Aikawa T.
    Am J Gastroenterol; 1996 Jun; 91(6):1195-203. PubMed ID: 8651170
    [Abstract] [Full Text] [Related]

  • 24. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.
    El-Serag HB, Richardson PA, Everhart JE.
    Am J Gastroenterol; 2001 Aug; 96(8):2462-7. PubMed ID: 11513191
    [Abstract] [Full Text] [Related]

  • 25. Seroprevalence of hepatitis B and C viral markers in patients with primary hepatocellular carcinoma in Singapore.
    Khin LW, Teo CJ, Guan R.
    Singapore Med J; 1996 Oct; 37(5):492-6. PubMed ID: 9046201
    [Abstract] [Full Text] [Related]

  • 26. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ, Kwon OS, Chung NS, Lee SY, Jung HS, Park DK, Ku YS, Kim YK, Kim YS, Kim JH.
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [Abstract] [Full Text] [Related]

  • 27. Hepatitis delta virus (HDV) infection and hepatocellular carcinoma (HCC).
    Oliveri F, Brunetto MR, Baldi M, Piantino P, Ponzetto A, Forzani B, Smedile A, Verme G, Bonino F.
    Prog Clin Biol Res; 1991 Mar; 364():217-22. PubMed ID: 1850527
    [No Abstract] [Full Text] [Related]

  • 28. Surgical results in patients with dual hepatitis B- and C-related hepatocellular carcinoma compared with hepatitis B- or C-related hepatocellular carcinoma.
    Chen MF, Jeng LB, Lee WC, Chen TC.
    Surgery; 1998 May; 123(5):554-9. PubMed ID: 9591008
    [Abstract] [Full Text] [Related]

  • 29. [Risk factors and prevention of hepatocellular carcinoma].
    Tanaka K.
    Fukuoka Igaku Zasshi; 1997 Oct; 88(10):325-30. PubMed ID: 9432489
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy.
    Franceschi S, Montella M, Polesel J, La Vecchia C, Crispo A, Dal Maso L, Casarin P, Izzo F, Tommasi LG, Chemin I, Trépo C, Crovatto M, Talamini R.
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):683-9. PubMed ID: 16614109
    [Abstract] [Full Text] [Related]

  • 32. Hepatocellular carcinoma: pathogenetic implications of the hepatitis delta virus.
    Oliveri F, Colombatto P, Derenzini M, Trere D, Papotti M, David E, Negro F, Bellati G, Ideo G, D'Aquino M.
    Prog Clin Biol Res; 1993 Apr; 382():165-70. PubMed ID: 8389050
    [No Abstract] [Full Text] [Related]

  • 33. Viral pathogenesis of hepatocellular carcinoma in the United States.
    Liang TJ, Jeffers LJ, Reddy KR, De Medina M, Parker IT, Cheinquer H, Idrovo V, Rabassa A, Schiff ER.
    Hepatology; 1993 Dec; 18(6):1326-33. PubMed ID: 8244256
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Aetiological differences in demographical, clinical and pathological characteristics of hepatocellular carcinoma in The Gambia.
    Umoh NJ, Lesi OA, Mendy M, Bah E, Akano A, Whittle H, Hainaut P, Kirk GD.
    Liver Int; 2011 Feb; 31(2):215-21. PubMed ID: 21143369
    [Abstract] [Full Text] [Related]

  • 36. [Breakthrough in human hepatocellular carcinogenesis--from hepatitis B virus to hepatitis C virus].
    Nishioka K.
    Gan To Kagaku Ryoho; 1991 Mar; 18(3):327-36. PubMed ID: 1848417
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Ornithine decarboxylase activity in the non-cancerous hepatic tissue of patients with hepatocellular carcinoma.
    Kubo S, Tamori A, Omura T, Ikebe T, Wakasa K, Hirohashi K, Kinoshita H, Otani S.
    Hepatogastroenterology; 2000 Mar; 47(33):820-3. PubMed ID: 10919038
    [Abstract] [Full Text] [Related]

  • 40. Comparison of the characteristics of hepatocellular carcinoma between hepatitis B and C viral infection: tumor multicentricity in cirrhotic liver with hepatitis C.
    Miyagawa S, Kawasaki S, Makuuchi M.
    Hepatology; 1996 Aug; 24(2):307-10. PubMed ID: 8690397
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.